Investor Stock List
Ranked #5,766 of 8,699 institutional investors

Enavate Sciences GP, LLC

New York, NY

$231M
US stock portfolio at live prices · today −$1.6M (−0.67%)
Market closed. Prices as of Nov 20, 6:11 AM ET
Value at quarter end (Q3 2026)
$280M
Change from Q2 2026
−$65.6M (−19.00%)
Positions
8 · 1 new, 0 sold out
Filed
Nov 16, 2026

Holdings

Q3 2026 13F, live prices
ZBIO 31.7%BRVE 30.7%IMNM 26.0%SION 3.19%CMPX 2.29%
StockSharesValue, live% of portfoliovs Q2 2026
ZBIO Zenas BioPharma, Inc.2,919,159$73.1M31.7%Reduced −26%
BRVE Braveheart Bio, Inc.3,674,656$70.8M30.7%New
IMNM Immunome, Inc.3,613,799$60.0M26.0%Unchanged
SION Sionna Therapeutics, Inc.2,478,030$7.4M3.19%Unchanged
CMPX Compass Therapeutics, Inc.7,788,150$5.3M2.29%Unchanged
UPB Upstream Bio, Inc.2,459,703$4.9M2.13%Unchanged
BBOT BridgeBio Oncology Therapeutics, Inc.2,626,946$4.9M2.12%Unchanged
CAMP Camp4 Therapeutics Corp1,041,127$4.2M1.81%Reduced −27%